S.Amdt. 1809
What it does: Adds SEC. 3136. SENSE OF THE SENATE ON PRODUCTION OF MOLYBDENUM-99 at the end of subtitle C of title XXXIWhat it changes
1 change to S. 1390 · shown in the bill's text
Adds SEC. 3136. SENSE OF THE SENATE ON PRODUCTION OF MOLYBDENUM-99 at the end of subtitle C of title XXXI
Adds a sectionIn S. 1390 · Placed on Calendar Senate
The Secretary of Energy shall include in the budget justification materials submitted to Congress in support of the Department of Energy budget for a fiscal year (as submitted with the budget of the President under section 1105(a) of title 31, United States Code) specific identification, as a budgetary line item, of the amounts required to meet the pension obligations of the Department of Energy for contractor employees at each facility of the Department of Energy operated using amounts authorized to be appropriated for the Department of Energy for the National Nuclear Security Administration or for defense environmental cleanup.
Inserted: SEC. 3136. SENSE OF THE SENATE ON PRODUCTION OF MOLYBDENUM-99.
Inserted: (a) Findings.--The Senate makes the following findings:
Inserted: (1) There are fewer than five reactors around the world currently capable of producing molybdenum-99 (Mo-99) and there are no such reactors in the United States that can provide a reliable supply of Mo-99 to meet medical needs.
Inserted: (2) Since November 2007, there have been major disruptions in the global availability of Mo-99, including at facilities in Canada and the Netherlands, which have led to shortages of Mo-99-based medical products in the United States and around the world.
Inserted: (3) Ensuring a reliable, supply of medical radioisotopes, including Mo-99, is of great importance to the public health.
Inserted: (4) It is also a national security priority of the United States, and specifically of the Department of Energy, to encourage the production of low-enriched uranium-based radioisotopes in order to promote a more peaceful international nuclear order.
Inserted: (5) The National Academy of Sciences has identified a need to establish a reliable capability in the United States for the production of Mo-99 and its derivatives for medical purposes using low-enriched uranium.
Inserted: (6) There also exists a capable industrial base in the United States that can support the development of Mo-99 production facilities and can conduct the processing and distribution of radiopharmaceutical products for use in medical tests worldwide.
Inserted: (b) Sense of the Senate.--It is the sense of the Senate that--
Inserted: (1) radioisotopes and radiopharmaceuticals, including Mo-99 and its derivatives, are essential components of medical tests that help diagnose and treat life-threatening diseases affecting millions of people each year; and
Inserted: (2) the Secretary of Energy should continue and expand a program to meet the need identified by the National Academy of Sciences to ensure a source of Mo-99 and its derivatives for use in medical tests to help ensure the health security of the United States and around the world and promote peaceful nuclear industries through the use of low-enriched uranium.
Original wording
At the end of subtitle C of title XXXI, add the following:
Read automatically from the Congressional Record. Check the original before relying on it.
As printed
SA 1809. Mrs. McCASKILL submitted an amendment intended to be proposed by her to the bill S. 1390, to authorize appropriations for fiscal year 2010 for military activities of the Department of Defense, for military construction, and for defense activities of the Department of Energy, to prescribe military personnel strengths for such fiscal year, and for other purposes; which was ordered to lie on the table; as follows:
At the end of subtitle C of title XXXI, add the following:
SEC. 3136. SENSE OF THE SENATE ON PRODUCTION OF MOLYBDENUM-99.
(a) Findings.--The Senate makes the following findings:
(1) There are fewer than five reactors around the world currently capable of producing molybdenum-99 (Mo-99) and there are no such reactors in the United States that can provide a reliable supply of Mo-99 to meet medical needs.
(2) Since November 2007, there have been major disruptions in the global availability of Mo-99, including at facilities in Canada and the Netherlands, which have led to shortages of Mo-99-based medical products in the United States and around the world.
(3) Ensuring a reliable, supply of medical radioisotopes, including Mo-99, is of great importance to the public health.
(4) It is also a national security priority of the United States, and specifically of the Department of Energy, to encourage the production of low-enriched uranium-based radioisotopes in order to promote a more peaceful international nuclear order.
(5) The National Academy of Sciences has identified a need to establish a reliable capability in the United States for the production of Mo-99 and its derivatives for medical purposes using low-enriched uranium.
(6) There also exists a capable industrial base in the United States that can support the development of Mo-99 production facilities and can conduct the processing and distribution of radiopharmaceutical products for use in medical tests worldwide.
(b) Sense of the Senate.--It is the sense of the Senate that--
(1) radioisotopes and radiopharmaceuticals, including Mo-99 and its derivatives, are essential components of medical tests that help diagnose and treat life-threatening diseases affecting millions of people each year; and
(2) the Secretary of Energy should continue and expand a program to meet the need identified by the National Academy of Sciences to ensure a source of Mo-99 and its derivatives for use in medical tests to help ensure the health security of the United States and around the world and promote peaceful nuclear industries through the use of low-enriched uranium.
Legislative Activity
Stay on top of the latest movement without scrolling through every action
Senate amendment submitted
July 23, 2009